Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)Matthew J. Rees, Hang Quach, Rosemary Harrup et al.|Blood|2025Cited by 3
The <scp>PINNACLE</scp> study: A multicentre phase <scp>II</scp> trial of nilotinib in combination with pegylated interferon‐α2b in newly diagnosed chronic phase chronic myeloid leukaemiaDavid T. Yeung, the Australasian Leukaemia and Lymphoma Group, Andrew P. Grigg et al.|British Journal of Haematology|2025Cited by 1